We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-3.25%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.01B
AUM Growth
+$262M
Cap. Flow
-$162M
Cap. Flow %
-2.7%
Top 10 Hldgs %
51.52%
Holding
592
New
224
Increased
125
Reduced
42
Closed
159

Top Buys

Rank Stock Value
1
WAY
Waystar Holding Corp
WAY
+$107M
2
GILD icon
Gilead Sciences
GILD
+$99.5M
3
CVS icon
CVS Health
CVS
+$61M
4
BAX icon
Baxter International
BAX
+$57.9M
5
CGEM icon
Cullinan Oncology
CGEM
+$45.6M

Top Sells

Rank Stock Value
1
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$136M
2
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$80.7M
3
SWTX
SpringWorks Therapeutics
SWTX
+$63.2M
4
OSCR icon
Oscar Health
OSCR
+$44.4M
5
VKTX icon
Viking Therapeutics
VKTX
+$38M

Sector Composition

Rank Sector Weight
1 Healthcare 83.29%
2 Industrials 0.69%
3 Technology 0.57%
4 Financials 0.44%
5 Consumer Discretionary 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CFG icon
151
Citizens Financial Group
CFG
$30.4B
$896K 0.01%
+24,879
New +$868K
HCC icon
152
Warrior Met Coal
HCC
$4.23B
$895K 0.01%
14,264
+10,664
+296% +$691K
MU icon
153
Micron Technology
MU
$1.04T
$893K 0.01%
6,793
+2,996
+79% +$378K
CNO icon
154
CNO Financial Group
CNO
$4.97B
$889K 0.01%
32,062
+19,147
+148% +$523K
PRGS icon
155
Progress Software
PRGS
$1.55B
$881K 0.01%
16,238
-3,156
-16% -$160K
FFIC
156
DELISTED
Flushing Financial
FFIC
$873K 0.01%
66,357
+26,067
+65% +$318K
ARIS
157
DELISTED
Aris Water Solutions
ARIS
$870K 0.01%
55,490
+41,090
+285% +$615K
CTKB icon
158
Cytek Biosciences
CTKB
$576M
$869K 0.01%
+155,759
New +$936K
HSIC icon
159
Henry Schein
HSIC
$9.74B
$864K 0.01%
+13,479
New +$949K
HAIN icon
160
Hain Celestial
HAIN
$47.8M
$861K 0.01%
124,589
+99,246
+392% +$682K
LRCX icon
161
Lam Research
LRCX
$382B
$855K 0.01%
+8,030
New +$770K
CMS icon
162
CMS Energy
CMS
$23.1B
$854K 0.01%
+14,354
New +$869K
OMCL icon
163
Omnicell
OMCL
$1.86B
$852K 0.01%
31,474
+22,174
+238% +$642K
ULTA icon
164
Ulta Beauty
ULTA
$20.4B
$845K 0.01%
2,191
+1,250
+133% +$508K
PNC icon
165
PNC Financial Services
PNC
$100B
$822K 0.01%
+5,290
New +$820K
EXPO icon
166
Exponent
EXPO
$2.98B
$822K 0.01%
8,641
+5,867
+211% +$529K
SITM icon
167
SiTime
SITM
$16.6B
$819K 0.01%
+6,587
New +$702K
CBT icon
168
Cabot Corp
CBT
$4.65B
$819K 0.01%
+8,914
New +$864K
WBD icon
169
Warner Bros
WBD
$64.6B
$817K 0.01%
109,825
+62,479
+132% +$501K
SLP icon
170
Simulations Plus
SLP
$371M
$811K 0.01%
+16,674
New +$786K
BMRN icon
171
BioMarin Pharmaceuticals
BMRN
$11.5B
$809K 0.01%
+9,832
New +$819K
NAMSW icon
172
NewAmsterdam Pharma Warrant
NAMSW
$809K 0.01%
92,787
– –
NTNX icon
173
Nutanix
NTNX
$14.9B
$808K 0.01%
+14,207
New +$872K
FERG icon
174
Ferguson
FERG
$44.7B
$797K 0.01%
+4,118
New +$864K
VEEV icon
175
Veeva Systems
VEEV
$30.3B
$785K 0.01%
4,292
+3,120
+266% +$619K
5 6
7
8 9

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q2 2024 Portfolio in Review

As of Q2 2024, Deerfield Management held 592 positions worth $6.01B, up 4.6% from $5.75B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q2 2024 filing shows 224 new, 125 increased, 42 reduced and 159 closed positions. Its largest new stake was Waystar Holding Corp: 4,952,004 shares worth $106M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $136M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 89% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q2 2024 buy was Waystar Holding Corp: 4,952,004 shares worth $106M.
  • Deerfield Management added most to Baxter International in Q2 2024, an estimated $57.9M increase.
  • Deerfield Management's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $44.4M.
  • Deerfield Management fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $136M.
  • Deerfield Management's ten largest holdings make up 52% of its $6.01B portfolio in Q2 2024.
  • Deerfield Management opened 224 new positions and closed 159 in Q2 2024.
  • Deerfield Management's portfolio value rose 4.6% quarter-over-quarter to $6.01B.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.